Korean

R&D Highlights

R&D Pipeline
R&D
HOME >  R&D Highlights >  R&D
01

Multi-Component Multi-Target(MCMT) approach

  • Solving the limitations of single-target treatment for chronic intractable diseases
  • Development of disease modifying natural drug products to treat chronic intractable diseases
  • 02

    Core Technology Platform

  • AI virtual human body system-based core technology
  • Specialized for MCMT treatment
  • Network modeling and integrated analysis technology
  • Multicomponent and complex mechanism analysis
  • Clinical efficacy prediction → Increase of clinical success↑
  • 03

    Core Technology Platform : Technology Commercialization Status

    2020
    SyMThomics v1.0(2020.02)
    • Development of a Multi-Active Ingredient Analysis Platform
    • Chemical Profiling
    • Development of Multi-Omics Analysis Platform
    • Omics Profiling in Disease Animal Models
    • Identification and Validation of Multi-target MoA
    2021
    SyMThomics v1.1(2021.05)
    2022
    Implementation of AI & Big Data Analytics
    • CODA: Virtual Human System DB
    • COCONUT: Integrated Natural Products DB
    2023
    SyMThomics v1.2(2023.06)
    • Enhancement of AI-driven Models for Neurodegenerative Disorders
    2024
    SyMThomics v2.0(2024.09)
    • Enhancement of AI-driven Models for Advancing Commercialization of Platform Technologies
    • 01. Elucidating the Therapeutic Efficacy of MT101 in Enhancing Nurr1 Activity and α-synuclein Clearance

    • 02. Identification of Proteasome-Activating Components in MT101

    • 03. Elucidating the Efficacy of MT9801 in Nerve Regeneration and Pain Reduction

    • 04. Elucidating the Efficacy of MT102 in AhR Activation and NLRP3 Inflammasome Inhibition

    04

    Core Infrastructure : CMC
    (Chemistry Manufacturing and Controls)

    • Research on cultivation from seeds to raw materials
    • Establishing specifications with high similarity between production batches to manufacture high-quality API
    • Quality control by setting mass balance centered on active ingredients